Abstract
Breast cancers are highly variable with regard to pathological and clinical features. While various different cancers being at different stages of tumor progression might explain some of this variability, we must also consider evidence that breast cancers can also develop along different molecular pathways. This manuscript discusses the extensive heterogeneity of breast cancer at the pathological and molecular level, reviewing evidence for a breast cancer progression model as well as evidence that breast cancer is not a single disease. In addition to this heterogeneity among different breast cancers, there is often pathological and molecular heterogeneity among different areas within individual neoplasms. This heterogeneity within cancers probably reflects genetic instability, and could also explain the ability of breast cancers to adapt to new environmental situations. Understanding this heterogeneity, among different breast cancers as well as within individual cancers, is important for understanding the complexity of this disease and ultimately for managing breast cancer effectively.
Current Genomics
Title: Heterogeneity in the Pathology and Molecular Biology of Breast Cancer
Volume: 3 Issue: 5
Author(s): Edward Gabrielson and Pedram Argani
Affiliation:
Abstract: Breast cancers are highly variable with regard to pathological and clinical features. While various different cancers being at different stages of tumor progression might explain some of this variability, we must also consider evidence that breast cancers can also develop along different molecular pathways. This manuscript discusses the extensive heterogeneity of breast cancer at the pathological and molecular level, reviewing evidence for a breast cancer progression model as well as evidence that breast cancer is not a single disease. In addition to this heterogeneity among different breast cancers, there is often pathological and molecular heterogeneity among different areas within individual neoplasms. This heterogeneity within cancers probably reflects genetic instability, and could also explain the ability of breast cancers to adapt to new environmental situations. Understanding this heterogeneity, among different breast cancers as well as within individual cancers, is important for understanding the complexity of this disease and ultimately for managing breast cancer effectively.
Export Options
About this article
Cite this article as:
Gabrielson Edward and Argani Pedram, Heterogeneity in the Pathology and Molecular Biology of Breast Cancer, Current Genomics 2002; 3 (5) . https://dx.doi.org/10.2174/1389202023350327
DOI https://dx.doi.org/10.2174/1389202023350327 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
TGF-β2 Signaling in High-Grade Gliomas
Current Pharmaceutical Biotechnology Microtubules in Apoptosis Induction: Are They Necessary?
Current Cancer Drug Targets The S100A8 and S100A9 Proteins are Attractive Targets to Modulate Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Applications of Lipid based Formulation Technologies in the Delivery of Biotechnology-based Therapeutics
Current Pharmaceutical Biotechnology New Insights of CTLA-4 into Its Biological Function in Breast Cancer
Current Cancer Drug Targets COX-2 and Colorectal Cancer
Current Pharmaceutical Design Implication of Complement System and its Regulators in Alzheimers Disease
Current Neuropharmacology Understanding and Applying Personalized Therapeutics at Systems Level:Role for Translational Bioinformatics
Current Pharmacogenomics and Personalized Medicine Editorial (Thematic Issue: Novel Methods and Tools of the Computational Systems Biology in Bioinformatics and Biomedical Informatics)
Current Bioinformatics The Potential of PI3K/AKT/mTOR Signaling as a Druggable Target for Endometrial and Ovarian Carcinomas
Current Drug Targets Molecular Genetics and Epidemiology of Osteoporosis
Current Pharmacogenomics An Investigative Approach to Treatment Modalities for Squamous Cell Carcinoma of Skin
Current Drug Delivery Breast Reconstruction – A Historical Perspective on Available Techniques for Patients Electing Bilateral Mastectomy
Current Cancer Therapy Reviews Antioxidant, Antimicrobial Activity and Medicinal Properties of Grewia asiatica L.
Medicinal Chemistry Metabolomics as a Tool for Drug Discovery and Personalised Medicine. A Review
Current Topics in Medicinal Chemistry A Novel Recombinant Multi-Epitope Vaccine Could Induce Specific Cytotoxic T Lymphocyte Response <i>In Vitro</i> and <i>In Vivo</i>
Protein & Peptide Letters Anthocyanins As Modulators of Cell Redox-Dependent Pathways in Non-Communicable Diseases
Current Medicinal Chemistry Biologically Active Selenophenes and Benzo[b]selenophenes
Current Organic Synthesis Emerging Drug Target In Pancreatic Cancer: Placing Sirtuin 1 on the Canvas
Current Cancer Drug Targets Development of Novel Therapeutics Targeting Isocitrate Dehydrogenase Mutations in Cancer
Current Topics in Medicinal Chemistry